1International Classification of Diseases and Related Health Problems, 10th Revision. Geneva. World Health Organization, 1992.Google Scholar

2Blencowe, H, Cousens, S, Oestergaard, MZ, Chou, D, Moller, AB, Narwal, R, et al.National, regional and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379: 2162–72.Google Scholar

3Beck, S, Wojdyla, D, Say, L, Betran, AP, Merialdi, M, Requejo, JH, et al.The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88 (1): 31–9.Google Scholar

4Colvin, M, McGuire, W, Fowlie, PW. ABC of preterm birth: neurodevelopmental outcomes after preterm birth. BMJ 2004; 329: 1390–93.CrossRefGoogle Scholar

5Khashu, M, Narayanan, M, Bhargava, S, Osiovich, H. Perinatal outcomes associated with preterm birth at 33 to 36 weeks’ gestation: a population-based cohort study. Pediatrics 2009; 123: 109–13.Google Scholar

6Moster, D, Lie, RT, Markestad, T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008; 359: 262–73.CrossRefGoogle ScholarPubMed

7Davis, L, Edwards, H, Mohay, H, Wollin, J. The impact of very premature birth on the psychological health of mothers. Early Hum Dev 2003; 73 (1): 61–70.Google Scholar

8Tucker, J, McGuire, W. ABC of preterm birth: epidemiology of preterm birth. BMJ 2004; 329: 675–8.Google Scholar

9Pennell, CE, Jacobsson, B, Williams, SM, Buus, RM, Muglia, LJ, Dolan, SM. Genetic epidemiologic studies of preterm birth: guideline for research. Am J Obstet Gynaecol 2007; 196: 107–18.Google Scholar

10Norman, JE, Morris, C, Chalmers, J. The effect of changing patterns of obstetric care in Scotland (1980–2004) on rates of preterm birth and its neonatal consequences: perinatal database study. PLoS Med 2009; 6 (9): e1000153.CrossRefGoogle ScholarPubMed

11Wood, CE. Control of parturition in women. J Reprod Fertil (Suppl) 1999; 54: 115–26.Google Scholar

12Mesiano, S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynaecol Invest 2004; 11: 193–202.Google Scholar

13Csapo, A, Pinto-Dantas, CA. The effect of progesterone on the human uterus. Proc Natl Acad Sci USA 1965; 54 (4): 1069–76.CrossRefGoogle ScholarPubMed

14Grazzini, E, Guillon, G, Mouillac, B, Zingg, HH. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998; 392: 509–12.Google Scholar

15Mesiano, S, Wang, Y, Norwitz, ER. Human pregnancy uterus: do they hold the key to birth timing? Reprod Sci 2011; 18 (1): 6–19.Google Scholar

16Brown, AG, Leite, RS, Strauss III, JF. Mechanisms underlying “functional” progesterone withdrawal at parturition. Ann NY Acad Sci 2004; 1034: 36–49.CrossRefGoogle ScholarPubMed

17Mesiano, S, Chan, EC, Fitter, JT, Kwek, K, Yeo, G, Smith, R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor a expression in the myometrium. J Clin Endocrinol Metab 2002; 87 (6): 2924–30.CrossRefGoogle ScholarPubMed

18Smith, R, Mesiano, S, Chan, EC, Brown, S, Jaffe, RB. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998; 83: 2359–44.Google ScholarPubMed

19Jones, SA, Challis, JR. Effects of corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynaecol Obstet Invest 1990; 29 (3): 165–8.Google Scholar

20McLean, M, Smith, R. Corticotrophin-releasing hormone and human parturition. Reproduction 2001; 121: 493–501.CrossRefGoogle ScholarPubMed

21Calder, AA. Prostaglandins and biological control of cervical function. Aus NZ J Obstet Gynaecol 1994; 34 (3): 347–51.CrossRefGoogle ScholarPubMed

22Mesiano, S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynaecol Invest 2004; 11 (4): 193–202.CrossRefGoogle ScholarPubMed

23Critchley, H, Bennett, P, Thornton, S (eds). Preterm birth. London: RCOG Press, 2004.Google Scholar

24Romero, R, Mazor, M, Munoz, H, Gomez, R, Galasso, M, Sherer, DM. The preterm labour syndrome. Ann NY Acad Sci 1994; 734: 414–29.Google Scholar

25Villar, J, Papageorghiou, AT, Knight, HE, Gravett, MG, Iams, J, Waller, SA, et al.The preterm birth syndrome: a prototype phenotypic classification. Am J Obstet Gynaecol 2012; 206 (2): 119–23.Google Scholar

26Renthal, NE, Chen, CC, Williams, KC, Gerard, RD, Prange-Kiel, J, Mendelson, CR. miR-200 family and targets, zeb1 and zeb2, modulate uterine quiescence and contractility during pregnancy and labour. Proc Natl Acad Sci USA 2010; 107 (48): 20828–33.Google Scholar

27Elovitz, M, Wang, Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intra-uterine fetal demise. Am J Obstet Gynaecol 2004; 190 (3): 693–701.Google Scholar

28Ito, A, Imada, K, Sato, T, Kubo, T, Matsushima, K, Mori, Y. Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem J 1994; 301: 183–6.Google Scholar

29Meis, PJ, Klebanoff, M, Thom, E, Dombrowski, MP, Sibai, B, Moawad, AH, et al.Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesteronecaproate. N Engl J Med 2003; 348: 2379–85.Google Scholar

30Rai, P, Rajaram, S, Goel, N, AyalurGopalakrishnan, R, Agarwal, R, Mehta, S. Oral micronized progesterone for prevention of preterm birth. Int J Gynaecol Obstet 2009; 104: 40–3.Google Scholar

31da Fonseca, EB, Bittar, RE, Carvalho, MH, Sugaib, M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419–24.Google Scholar

32Society for Maternal-Fetal Medicine Publications Committee. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynaecol 2012; 206 (5): 376–86.CrossRefGoogle Scholar

33Mackenzie, R, Walker, M, Armson, A, Hannah, MR. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomised controlled trials. Am J Obstet Gynaecol 2006; 194: 1234–42.CrossRefGoogle Scholar

34Dodd, JM, Crowther, CA, Cincotta, R, Flenady, V, Robinson, JS. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2005; 84: 526–33.Google Scholar

35Likis, FE, Velez Edwards, DR, Andrews, JC, Woodworth, AL, Jerome, RN, Fonnesbeck, CJ, et al.Progestogens for preterm birth prevention. Obstet Gynaecol 2012; 120: 897–907.Google Scholar

36Division of Reproductive and Urologic Products Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration. Proposed Indication: “Progesterone Gel 8% Is Indicated for the Reduction of Risk of Preterm Birth in Women with a Singleton Gestation and a Short Uterine Cervical Length in the Mid-Trimester of Pregnancy”. Beltsville, MD: Food and Drug Administration, 2011.Google Scholar

37Hassan, SS, Romero, R, Vidyadhari, D, Fusey, S, Baxter, JK, Khandelwal, M, et al.Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomised, double-blind, placebo-controlled trial. Ultrasound Obstet Gynaecol 2011; 38 (1): 18–31.Google Scholar

38Norman, JE, MacKenzie, F, Owen, P, Mactier, H, Hanretty, K, Cooper, S, et al.Progesterone for the Prevention of Preterm Birth in Twin Pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009; 373 (9680): 2034–40.Google Scholar

39Iams, JD, Goldenberg, RL, Meis, PJ, Mercer, BM, Moawad, A, Das, A, et al.The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996; 334: 567–72.Google Scholar

40Althusius, SM, Dekker, GA, Hummel, P, Bekedam, DJ, van Gejin, HP. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest, vs bed rest alone. Am J Obstet Gynecol 2011; 185: 1006–12.Google Scholar

41Owen, J, Hankins, G, Iams, JD, Berghella, V, Sheffiels, JS, Perez-Delboy, A, et al.Multicenter randomised trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynaecol 2009; 201: 375.e1–8.Google Scholar

42Berghella, V, Rafael, TJ, Szychowski, JM, Rust, OA, Owen, J. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynaecol 2011; 117: 663–71.Google Scholar

43Alfirevic, Z, Stampalija, T, Roberts, D, Jorgensen, AL. Cervical Stitch (Cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 2012; 8 (4): CD008891.Google Scholar

44Berghella, V, Mackeen, AD. Cervical length screening with ultrasound-indicated cerclage compared with history-indicated cerclage for prevention of preterm birth. Obstet Gynaecol 2011; 118: 148–55.Google Scholar

45Goya, M, Pratcorona, L, Merced, C, Rodo, C, Valle, L, Romero, A, et al.Cervical Pessary in Pregnant Women with a Short Cervix (PECEP): an open-label randomised controlled trial. Lancet 2012; 379:1800–6.Google Scholar

46Fonseca, EB, Celik, E, Parra, M, Singh, M, KH Nicolaides for the Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with short cervix. N Engl J Med 2007; 357: 462–9.CrossRefGoogle ScholarPubMed

47Plummer, CP. Evaluation of maternal and neonatal outcomes after maintenance tocolysis: a retrospective study. J Obstet Gynaecol Res 2012; 38 (1): 198–202.Google Scholar

48Gyetvai, K, Hannah, ME, Hodnett, ED, Ohlsson, A. Tocolytics for preterm labour: a systematic review. Obstet Gynaecol 1999; 94: 869–77.Google Scholar

49Anotayanonth, S, Subhedar, NV, Garner, P, Neilson, JP, Harigopal, S. Betamimetics in inhibiting preterm labour. Cochrane Database Syst Rev 2004; 4: CD004352.Google Scholar

50Papatsonis, D, Flenady, V, Cole, S, Liley, H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2010; 1: CD004452.Google Scholar

51Han, S, Crowther, CA, Moore, V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2010; 7: CD000940.Google Scholar

52Doyle, LW, Crowther, CA, Middleton, P, Marret, S, Rouse, D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2010; 3: CD004661.Google Scholar

53The Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel, Antenatal Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus, Infant and Child: National Clinical Practice Guidelines. Adelaide: The University of Adelaide, 2010.Google Scholar

54Royal College of Obstetricians and Gynaecologists. Magnesium Sulphate to Prevent Cerebral Palsy following Preterm Birth. Scientific Impact Paper No. 29. August 2011.Google Scholar

55King, JF, Flenady, VJ, Papatsonis, DN, Dekker, GA, Carbonne, B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2007; 4: CD002255.Google Scholar

56King, JF, Flenady, VJ, Cole, S, Thornton, S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2010; 2: CD001992.Google Scholar

57Haas, DM, Caldwell, DM, Kirkpatrick, P, McIntosh, JJ, Welton, NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012; 345: e6226.Google Scholar

58Royal College of Obstetrics and Gynaecologists. Tocolysis for Women in Preterm Labour. Green-Top Guideline No. 1b, February 2011Google Scholar

59Chang, HH, Larson, J, Blencowe, H, Spong, CY, Howson, CP, Cairns-Smith, S, et al.Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet 2013; 381: 223–34.Google Scholar

60Steer, P. The epidemiology of preterm birth. BJOG 2005; 112 (Suppl. 1): 1–3.Google Scholar

61Goldenberg, RL, Rouse, DJ. Prevention of premature birth. N Engl J Med 1998; 339 (5): 313–20.CrossRefGoogle ScholarPubMed

62Ananth, CV, Vintzileos, AM. Trends in caesarean delivery at preterm gestation and association with perinatal mortality. Am J Obstet Gynaecol 2011; 204 (6): 505.e1–8.Google Scholar

63Norman, JE, Bollapragada, S, Yuan, M, Nelson, SM. Inflammatory pathways in the mechanism of parturition. BMC Pregnancy Childbirth 2007; 7 (1): 57.Google Scholar

64Goldenberg, RL, Hauth, JC, Andrews, WW. Mechanism of disease – intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500–7.Google Scholar

65Kenyon, S, Boulvain, M, Neilson, JP. Antibiotics for Preterm Rupture of Membranes. Cochrane Database of Systematic Reviews 2010. 8. CD001058.Google Scholar

66Royal College of Obstetricians and Gynaecologists. Preterm Prelabour Rupture of Membranes. Green Top Guideline 44, November 2006 (Minor amendment October 2010).Google Scholar

67Kenyon, SL, Taylor, DJ, Tarnow-Mordi, W, for the ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 2001; 357: 989–94.Google Scholar

68Kenyon, SL, Pike, K, Jones, DR, Brocklehurst, P, Marlow, N, Salt, A, et al.Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008; 372 (9646): 1319–27.Google Scholar

69Marret, S, Gressens, P, Gadisseux, JF, Evrard, P. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 1995; 37 (6): 473–84.Google Scholar

70Maulik, D. Oxygen free radical generation during in-utero hypoxia in the fetal guinea pig brain: the effects of maturity and of magnesium sulphate administration. Brain Res 1999; 817: 117–22.Google Scholar

71Facchinetti, F, Battaglia, C, Bednatti, R, Borelia, P, Genazzani, AR. Oral magnesium supplementation improves fetal circulation. Magnes Res 1992; 5: 179–81.Google Scholar

72Wolf, HT, Hegaard, HK, Greisen, G, Huusom, L, Hedegaard, M. Treatment with magnesium sulphate in preterm birth: a systematic review and meta-analysis of observational studies. J Obstet Gynaecol 2012; 32 (2): 135–40.Google Scholar

73Roberts, D, Dalziel, SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth (Review). Cochrane Database Syst Rev 2013; 3: CD004454.Google Scholar

74Royal College of Obstetricians and Gynaecologists. Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. Green-Top Guideline No. 7. October 2010Google Scholar

75National Institutes of Health. Antenatal corticosteroids revisited: repeat courses. NIH Consensus Statement Online 2000; 17 (2): 1–10.Google Scholar

76Wapner, RJ, Sorokin, Y, Mele, L, Johnson, F, Dudley, DJ, Spong, CY, et al.Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 2007; 357: 1190–8.Google Scholar

77Murphy, KE, Hannah, ME, Willan, AR, Hewson, SA, Ohlsson, A, Kelly, EN, et al.Multiple Courses of Antenatal Corticosteroids for Preterm Birth (MACS): a randomised controlled trial. Lancet 2008; 372 (9656): 2143–51.Google Scholar

78Norman, JE, Shennan, A, Bennett, P, Thornton, S, Robson, S, Marlow, N, et al.Trial Protocol OPPTIMUM – does progesterone prophylaxis for the prevention of preterm labour improve outcome? BMC Pregnancy Childbirth 2012; 12: 79–87.Google Scholar